News on haematological malignancies
Cerdulatinib is an oral, dual Syk-JAK inhibitor with a unique mechanism of action. It inhibits…
Acute leukaemia is the most common cancer in childhood and the incidence is increasing especially…
Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with 8 or…
The risk of blood clots in the veins of the legs or the lungs, known…
An international research team has found a way to improve the anti-cancer effect of a…
Certain paediatric leukaemias share a common underlying cause with treatment-related secondary leukaemias. Both diseases involve…
In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of…
By Nicholas A. Abinya, University of Nairobi; Andrew Odhiambo, University of Nairobi; Esther Dindi, University…
Diagnosed with leukaemia in his early 40s, Chris Lihosit was saved by umbilical cord blood from three…
Although most patients with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced complete response after treatment…